Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Roozen, Geert V TPrins, Margaretha L M
van Binnendijk, Rob
den Hartog, Gerco
Kuiper, Vincent P
Prins, Corine
Janse, Jacqueline J
Kruithof, Annelieke C
Feltkamp, Mariet C W
Kuijer, Marjan
Rosendaal, Frits R
Roestenberg, Meta
Visser, Leo G
Roukens, Anna H E
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study.Published in
Annals of internal medicine 2022; 175(12):1771-1774DOI
10.7326/M22-2089PMID
36279543ae974a485f413a2113503eed53cd6c53
10.7326/M22-2089
Scopus Count
Collections
Related articles
- Safety and immunogenicity of intradermal administration of fractional dose CoronaVac(®), ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination.
- Authors: Chatsiricharoenkul S, Niyomnaitham S, Posen HJ, Toh ZQ, Licciardi PV, Wongprompitak P, Duangchinda T, Pakchotanon P, Chantima W, Chokephaibulkit K
- Issue date: 2022
- Comparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly.
- Authors: Seo YB, Choi WS, Lee J, Song JY, Cheong HJ, Kim WJ
- Issue date: 2014 Jul
- Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.
- Authors: Sablerolles RSG, Rietdijk WJR, Goorhuis A, Postma DF, Visser LG, Geers D, Schmitz KS, Garcia Garrido HM, Koopmans MPG, Dalm VASH, Kootstra NA, Huckriede ALW, Lafeber M, van Baarle D, GeurtsvanKessel CH, de Vries RD, van der Kuy PHM, SWITCH Research Group
- Issue date: 2022 Mar 10
- Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
- Authors: Soonawala D, Verdijk P, Wijmenga-Monsuur AJ, Boog CJ, Koedam P, Visser LG, Rots NY
- Issue date: 2013 Aug 12
- Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
- Authors: Ferri C, Ursini F, Gragnani L, Raimondo V, Giuggioli D, Foti R, Caminiti M, Olivo D, Cuomo G, Visentini M, Cacciapaglia F, Pellegrini R, Pigatto E, Urraro T, Naclerio C, Tavoni A, Puccetti L, Varcasia G, Cavazzana I, L'Andolina M, Ruscitti P, Vadacca M, Gigliotti P, La Gualana F, Cozzi F, Spinella A, Visalli E, Dal Bosco Y, Amato G, Masini F, Pagano Mariano G, Brittelli R, Aiello V, Caminiti R, Scorpiniti D, Rechichi G, Ferrari T, Monti M, Elia G, Franceschini F, Meliconi R, Casato M, Iannone F, Giacomelli R, Fallahi P, Santini SA, Zignego AL, Antonelli A
- Issue date: 2021 Dec